INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 116 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $54,000 | -46.5% | 11,657 | +2.9% | 0.00% | -100.0% |
| Q3 2017 | $101,000 | -26.8% | 11,324 | +3.8% | 0.00% | 0.0% |
| Q2 2017 | $138,000 | -24.6% | 10,909 | -4.6% | 0.00% | 0.0% |
| Q1 2016 | $183,000 | +4.0% | 11,435 | +86.4% | 0.00% | 0.0% |
| Q4 2015 | $176,000 | -10.7% | 6,134 | -11.4% | 0.00% | 0.0% |
| Q3 2015 | $197,000 | -71.7% | 6,923 | -64.2% | 0.00% | -80.0% |
| Q2 2015 | $695,000 | +20.0% | 19,362 | +94.5% | 0.01% | +66.7% |
| Q1 2015 | $579,000 | +36.9% | 9,953 | -0.7% | 0.00% | +50.0% |
| Q4 2014 | $423,000 | +185.8% | 10,025 | +163.3% | 0.00% | +100.0% |
| Q3 2014 | $148,000 | – | 3,808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
| Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
| JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
| Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
| 12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
| Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
| Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
| Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
| Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |